期刊文献+

芪银三两三方治疗老年社区获得性肺炎36例临床观察 被引量:6

Clinical Observation on Qiyin Sanliangsan Formula for 36 Cases of Elderly Community Acquired Pneumonia
原文传递
导出
摘要 目的观察芪银三两三方治疗老年社区获得性肺炎的疗效。方法将71例患者随机分为治疗组36例和对照组35例,两组均予对症处理及抗生素治疗,在此基础上治疗加用芪银三两三方,疗程均为14天。疗程结束后观察2组患者的临床疗效,比较治疗前后症状积分变化和肺部炎症改善率。结果治疗组总有效率为91.7%,对照组总有效率为71.4%,两组比较差异有统计学意义(P<0.05);发热、咳嗽、咯痰的症状积分治疗前后差值比较,治疗组优于对照组(P<0.05);治疗组肺部炎症改善率(88.9%)与对照组(77.1%)比较,差异有统计学意义(P<0.05)。结论芪银三两三方治疗老年社区获得性肺炎有效,且在改善主要症状及促进炎症吸收上效果突出。 Objective To observe the therapeutic effect of Qiyin Sanliangsan Formula [formula of huangqi (RadixAstragali) and Jinyinhua (Flos Lonicerae Japonicae)] on elderly community acquired pneumonia (CAP). Methods Seventy one patients were randomized into treatment group of 36 cases and control group of 35 cases. Both groups were given symptomatic treatment and antibiotics and the treatment group was combined with Qiyin Sanliangsan Formula. The treatment course lasted for 14 days. The therapeutic effect, symptom integral and the relief rate of lung inflammation were observed and compared be- fore and after the treatment in both groups. Results The total effective rate of the treatment group and the control group was 91.7 % and 71.4% respectively, with significant difference (P〈0.05). After the treatment, there were significant differences between groups in the integrals of fever, cough and expectoration (P〈0. 05). The relief rate of lung inflammation of the treatment group and the control group was 88.9% and 77.1% respectively, with significant difference (P〈0. 05). Conclusion Qiyin Sanliangsan Formula is effective for the elderly CAP, especially in reliving the main symptoms and promoting inflammation absorption.
出处 《中医杂志》 CSCD 北大核心 2012年第13期1116-1118,共3页 Journal of Traditional Chinese Medicine
关键词 社区获得性肺炎 芪银三两三方 老年 community acquired pneumonia Qiyin Sanliangsan Formula[formula of huangqi (Radix Astragali) and Jinyinhua(Flos Lonicerae Japonicae) ] elderly
  • 相关文献

参考文献8

二级参考文献31

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:792
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3208

同被引文献156

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部